Perception of sound is a fundamental role of the auditory system. Traveling with the force of their mechanical energy, sound waves are captured by the ear and activate the sensory pathway of this complex organ. The hair cells, specialized sensory cells within the inner ear, transmit the mechanical energy into electrical nerve stimuli that reach the brain. A large number of proteins are responsible for the overarching tasks required to maintain the complex mechanism of sound sensation. Many hearing disorders are due to single gene defects inherited in a Mendelian fashion, thus enabling clinical diagnostics. However, at the same time, hearing impairment is genetically heterogeneous, with both common and rare forms occurring due to mutations in over 100 genes. The crosstalk between human and mouse genetics has enabled comprehensive studies on gene identification and protein function, taking advantage of the tools animal models have to offer. The aim of the following review is to provide background and examples of human deafness genes and the discovery of their function in the auditory system.
Hearing loss: a Mendelian disorder
Hearing loss is the most common sensory loss, affecting 1-2 out of 1,000 newborns and over half of the population by the age of 80 (U.S. National Institute on Deafness and Other Communication Disorders, http://www.nidcd.nih.gov/health/statistics/ hearing.html). Severe hearing loss that occurs during infancy can have dramatic effects on speech acquisition and literacy. Deafness with a later onset might have a deleterious effect on the quality of life of an affected individual. Hearing loss may be sensorineural, caused by damage to the inner ear or auditory nerve, or conductive, due to reduction of sound waves passing through the outer and middle ear (reviewed in Ref. 1) . Sensorineural hearing loss can be present at birth or acquired at later stages in life. Among the factors causing acquired hearing loss are effects from different infections and diseases and ototoxic drugs, as well as exposure to excessive noise, either social or industrial. Approximately 60-70% of hearing loss is due to genetic factors and is genetically heterogeneous, with single gene defects in many different genes (Fig. 1) . 4 Genetic hearing impairment can occur either as syndromic hearing loss (SHL), associated with other abnormalities, or nonsyndromic hearing loss (NSHL) as an isolated phenotype, which accounts for about 70% of the cases. Vestibular dysfunction may be associated with NSHL as well. Hearing loss can be inherited either in a dominant or recessive mode, whether it is syndromic or nonsyndromic. A comprehensive listing of all genes and the proteins they encode is no longer practical to complete in a review, as it was just a few years ago. The breadth and variability of phenotypes, mutations, mechanisms, and pathways is remarkable. Because the inner ear is an organ with diverse cell types, many cellular targets are susceptible to damage caused by genetic mutations. In this review, we concentrate on one of the most sensitive targets to genetic mutations, the hair cell, a sensory cell that functions to detect and amplify the mechanical signal evoked by sound, translating it into electrical signals that are transmitted to the brain. We define several characteristics and qualities of hereditary hearing loss. major mechanisms or functions of the inner ear and have shed light on auditory pathways. In each case, the mouse was instrumental in defining the mechanism. Each gene represents a different prototype of the variability and heterogeneity of hereditary hearing loss due to a single gene defect.
Hearing loss: from past to present
Descriptions of hereditary hearing loss go back as far as the 16th century. 5 In the early days of the 17th century, Paulus Zacchias (1584-1659), an Italian physician, stated that marriage of deaf people should be avoided, as they would give birth to deaf children like themselves. This statement suggests that Zacchias was aware of the hereditary factor in congenital deafness. In those days, however, it was still believed that hearing was the "gate of the mind," and therefore congenital deafness lead to defective intelligence. 6 By 1880, evidence for both autosomal dominant and autosomal recessive inheritances of hearing loss was presented, although the terms "autosomal dominant" and "autosomal recessive"
were not yet determined. X-linked inherited deafness is presumed to have been first described in 1863, although it was not fully characterized until 1930 by Dow and Poynter. 7 Prevention of marriage between deaf individuals was formally proposed in legislation in 1883, by Alexander Graham Bell. The approach of legally banning hearing-impaired individuals from society was taken even further under Nazi Germany and the embrace of eugenics. During Nazi control, 1,600 deaf individuals were murdered. 5 Today, there are many specialized schools and communities around the world for the deaf providing cultural centers and institutions of higher education, such as Gallaudet University in Washington DC, USA (http://www.gallaudet.edu/).
Syndromic hearing loss
SHL is known to be associated with defects in many different organs. 8 Forms of dominant SHL include Wardenburg syndrome (deafness, structural defects derived from the neural crest, and pigmentation anomalies); Branchial-oto-renal syndrome (Branchial fistulas, renal anomalies, and abnormal development of the ear); Stickler syndrome (distinctive facial abnormalities, eye problems, hearing loss, and joint problems), and neurofibromatosis 2 (characterized by tumors, including acoustic neuromas). Recessive SHL includes the deafness-blindness of Usher syndrome, Pendred syndrome (inner ear and enlargement of the thyroid gland, known as goiter), Jervell and LangeNielsen syndrome (characterized by electrocardiographic changes as well as hearing loss), and Cockayne syndrome (described with dwarfism, retinal atrophy, and deafness). X-linked syndromic deafness includes Alport syndrome (also known as hereditary nephritis) and Norrie disease (congenital ocular symptoms with progressive hearing loss). It is difficult to state how many forms of SHL there are. Hearing impairment is often overlooked because of other disorders present in patients. Toriello once estimated that "new" syndromes are being described weekly. 9 At least 32 genes have been identified for SHL (Hereditary Hearing Loss Homepage, http://hereditaryhearingloss.org). 
Nonsyndromic hearing loss
Since the early 1990s, 149 NSHL loci have been identified and are marked as DFNA, for autosomal dominant, DFNB, for autosomal recessive, and DFNX, for X-linked loci (Hereditary Hearing loss Homepage). 2 The first dominant locus, DFNA1, was identified in 1992 10 in a large kindred from Costa Rica. Five years later, the gene DIAPH1, which encodes the protein diaphanous that regulates actin polymerization, was found to be responsible for the hearing loss in this family.
11 DFNB1, the first recessive deafness locus identified, was revealed in 1994 in two consanguineous families from Tunisia that were affected by this form of deafness. 12 The responsible gene, GJB2, identified soon after in 1997, encodes the gap-junction protein connexin 26 (Cx26). 13 Today, GJB2 is the most common deafness-causing gene, accounting for up to 50% of the cases of nonsyndromic sensorineural hearing loss in some populations. 14 In 1995 the first sex-linked hearing loss-causing gene was identified, POU3F4, 15 which encodes a transcription factor with a POU domain; POU3F4 mapped to the interval of Xq21 and was found to be responsible for DFNX2. DFNX2 was formerly known as DFN3, but when a Y-linked deafness locus was identified 16 the nomenclature was changed to provide differentiation between the sex chromosomes.
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Major breakthroughs defining auditory function
Several major discoveries uncovered mechanisms of auditory function, combining gene and protein networks. Myosin VIIA mutations, associated with both Usher syndrome and NSHL, encode a protein that is part of the Usher network of proteins that interact with one another and help define functions of the stereocilia. Cadherin 23 and protocadherin 15 mutations are associated with both syndromic and nonsyndromic forms of hearing loss. Most compelling, these proteins together form the tip link between stereocilia, a major site of mechanotransduction. Mutations in stereocilin are associated with NSHL, and the loss of this protein leads to structural changes in the outer hair cells, implicating this protein in hair cell function. Finally, an entirely new paradigm in hearing loss was demonstrated with the discovery of mutations in a microRNA (miRNA). Together, these examples provide a snapshot of several different scenarios of this hereditary disease, which together form the complex function of the auditory system.
DFNB2/USH1B
An understanding of Usher syndrome on a molecular level has been achieved by defining part of the protein network in the inner ear that is responsible for development and mechanisms of the hair bundle. Usher syndrome is the most common cause of combined deafness-blindness known in humans, affecting 1:25,000 children. 18, 19 It is defined by congenital, bilateral deafness followed by a later onset of vision loss, caused by retinitis pigmentosa (RP). The retinal degeneration is a consequence of photoreceptor cell death beginning from the periphery of the retina. Patients suffer from night blindness, followed by narrowing of the visual field ("tunnel vision"), leading to absolute blindness. 20 Usher syndrome is heterogeneous, both clinically and genetically, with at least 12 chromosomal loci involved in the three types of USH syndrome, Usher type 1 (USH1), USH2, and USH3 (further subdivided, when relevant, to A-H). The different types are distinguishable from each other mainly by the severity and onset of deafness and the variability of vestibular defects, while all have RP. USH1 patients are profoundly deaf from birth and have vestibular dysfunction. The deafness in USH2 is less severe and the vestibular function is normal. USH3 is characterized by mild, progressive hearing loss with occasional vestibular dysfunction. 21 The first USH1 gene identified, for USH1B, was the gene encoding myosin VIIa (MYO7A). 22 Myosin VIIa is an unconventional myosin that moves toward the plus end of actin, from the stereocilia base to its tip; it has been described as a dimeric motor and is known to require high concentrations of ATP for its motile activity along actin filaments. 23 As part of the myosin superfamily, myosin VIIa has the common structure of myosins, a motor head domain that includes the actin-binding and the ATP-binding sites, a neck domain with five IQ motifs that are expected to bind myosin-light chains, and the variable tail domain. The tail region contains the functional domains that determine myosin VIIa specificity, 24 including two large tandem repeats that are separated by SH3 domains. These repeats consist of a MyTH4 (myosin tail homology 4) domain and a FERM domain (4.1, ezrin, readixin, moesin), which is thought to be responsible for the attachment of the protein to the plasma membrane. 19 The tail portion of myosin VIIa is known to bind the scaffolding proteins harmonin 25 and SANS, 19 as well as protocadherin15, 26 which are all part of the USH protein network, in addition to binding to the F-actin filaments (Fig. 2) . 23, 28 These interactions form the protein network of Usher syndrome. Myosin VIIa is also known to interact with vezatin, 29 which bridges myosin VIIa to the cadherin-catenin complex, thus increasing cell-cell adhesion. In the inner ear these two proteins have a membrane-to-membrane interaction in the links that interconnect the bases of adjacent stereocilia. Recently, a direct interaction between cadherin 23 and myosin VIIa was reported. 30 This finding enhances the relationship within the Usher protein network, as all of its components have been shown to interact with one another.
In addition to its involvement in Usher syndrome, mutations in myosin VIIA causes nonsyndromic deafness, either dominant (DFNA11 31 ) or recessive (DFNB2 32, 33 ). Myosin VIIa was also found to be mutated in the mutant Shaker1 (sh1) mouse, causing progressive degeneration of the cochlea (Fig. 2) together with vestibular dysfunction. 34 Myosin VIIa was found to be expressed in the cochlea as early as embryonic day 16.5. 35 The protein is expressed in the stereocilia and cuticular plate of the hair cells (Fig. 2) . 36 The Shaker-1 (sh1) gene has seven different alleles, and in some of the mutated alleles (Myo7a 6J and Myo7a 816SB in particular) the mutation causes abnormal stereocilia development in both inner and outer hair cells. 35 There is a high correlation between the location of the mutation within the protein and its severity. Mutations causing ultrastructural changes in the stereocilia were either deletions or missense mutations in the myosin motor-head core. Mutated forms of myosin VIIa fail to localize correctly to the stereocilia. 37 These mutated forms are responsible for the more severe phenotypes.
DFNB12/USH1D and DFNB23/USH1F
Mutations in CDH23 (cadherin-related 23) are responsible for both DFNB12 and USH1D. 38 Mutations were identified in a number of consanguineous families of Pakistanian and Indian origin 38 as well as a Cuban family. 39 The protein encoded by CDH23 comprises 3,354 amino acids and is predicted to have 27 cadherin repeats that are involved in Ca 2+ -dependent cell adhesion, an N terminal signal peptide, and one transmembrane domain. 40 Null mutations in this gene are associated with USH1D, whereas missense mutations are associated with DFNB12. 38, 41 The waltzer mouse phenotype is due to mutations in Cdh23 and serves as a mouse model for USH1D and DFNB12. 42, 43 These mice have hearing loss and vestibular dysfunction, caused by disorganization of their stereocilia (Fig. 3) . 43 Another mouse that suffers from progressive hearing loss and carries a mutation in Cdh23 is the N -ethyl-N -nitrosourea(ENU)-induced mouse salsa. 41 As opposed to the waltzer mouse, the hair bundle in the salsa mouse is intact and only the stereocilia tip-links are lost, presumably causing loss of tension within the stereocilia. Based on these two mouse models, it was suggested that USH1D, caused by null mutations in CDH23, is due to hair bundle developmental defects, while DFNB12, with the missense mutations, is caused by tip link defects. Cadherin 23 was shown to have a role in maintaining the hair bundle during development 43 but in adults has the role of comprising the tip links, transmitting the force to the ion channels. The tip links are extracellular filaments connecting between adjacent stereocilia and control the opening of mechanosensory transduction channels (Fig. 3) . 46 The mechanosensory channels are located near the stereocilia tips. Sound vibrations causes deflection of the hair bundle toward the longest stereocilia. This deflection increases the tension in the tip link and the hair cells will respond by opening or closing the ion transduction channels, 47 leading to an influx of cations into the stereocilia and resulting in depolarization of the hair cell.
Another component of the tip links is encoded by PCDH15 (protocadherin-15), 48 which has 11 calcium-binding cadherin repeats and is responsible for USH1F and DFNB23, as was identified in two Pakistani families. 49 In the syndromic form, affected members are profoundly deaf and suffer from progressive RP. The mouse model for USH1F is Ames waltzer, which is profoundly deaf with disorganized abnormal stereocilia (Fig. 3) . 50, 44 Protocadherin 15 forms the lower part of the tip link and interacts with cadherin 23, which forms the upper part, together creating the tip-link filament, 45 which is about 180nm long. The interaction between these two proteins is made through their extracellular cadherin domains, at their N terminus, and is Ca 2+ dependent. The salsa mutation also affects the interaction between cadherin 23 and protocadherin 15, even though the mutation affects an amino acid that is outside the interaction site. 41 The studies of these two proteins revealed the structure of the tip links, one of the most important components of the auditory hair bundle, which is important for both maintaining the highly organized structure of the stereocilia and playing a role in the mechanoelectrical (MET) process in the inner ear.
DFNB16
Mutation of the gene encoding stereocilin, Strc, is responsible for DFNB16, recessively inherited NSHL, found in two families of Pakistani and French origin. 51 The affected individuals have postlingual hearing loss from early childhood, which is more severe at higher frequencies. The stereocilin gene encodes an ∼1800 amino acid long protein that is localized at the tips of the stereocilia of the outer hair cells (Fig. 4) . Stereocilin was first hypothesized to be responsible for the attachment of the tectorial membrane to the sensory cells in the inner ear. 53 A mouse model lacking stereocilin 52 provided a clearer picture of the role of stereocilin in the inner ear. The tectorial membrane in these mice is intact but hair bundle imprinting, which represents the anchoring of outer hair cells stereocilia to the tectorial membrane, was not detectable. Outer hair cells derived from Strc −/− mice lack the horizontal top connectors. The distal ends of the stereocilia are less connected in the mutants than in wild-type mice, suggesting that the top connectors have a role in the cohesion of the outer hair cell hair bundle of adult mice. In the cochlea, the outer hair cells acts as an amplifier, assisting in sharpening the soundinduced mechanical stimulation that reaches the cochlea, while the inner hair cells serve to transmit the sensory information into the brain. The outer hair cells, in addition to sound amplification, generate mechanical and electrical waveform distortions, essential for hearing in noisy environments. 54 This distortion creates a masking effect that contributes to speech understanding and simplicity. The studies of Strc −/− mutant mice suggest that the top connectors may either generate distortion by themselves, due to nonlinear stiffness, or they may alter hair-bundle displacements, leading to distortion of sound waveforms. This work suggests a role for stereocilin in a major mechanism of outer hair cell function, revealed through genetic mutations.
DFNA50
MiRNAs are small noncoding RNAs, 21-23 nucleotides long, which regulate gene expression through the RNA interference (RNAi) mechanism, known to affect proliferation, differentiation, and developmental processes in eukaryotes. 55 Mir genes are included within introns of protein-coding genes or in intragenic regions. Intronic miRNAs are transcribed along with the host protein-coding gene. A miR is first transcribed to a long RNA molecule, the pri-miRNA, which is further processed by the nucleases Drosha and Dicer1 through the pre-miRNA intermediate to generate the mature miRNA. 56, 57 The seed sequence (nucleotides 2-8) of the mature miRNA is a key determinant of which mRNAs will be regulated by each miRNA. MiR genes are often organized in clusters that are cotranscribed as polycistronic genes to a single pri-miRNA from which a couple of mature miRNAs will originate. 58 MiR-96 is part of the miR-183/96/182 cluster, which is expressed in the mouse inner ear, retina, and additional tissues. [59] [60] [61] In the inner ear, it is mainly expressed in developing hair cells. The locus DFNA50 segregated in a Spanish family with postlingual, progressive, NSHL at all frequencies. 62 Further analysis revealed a mutation in miR-96 (+13 G > A), causing replacement of the fourth nucleotide within the conserved seed region of the mature miR-96 sequence, which segregated with the hearing impairment in the family. 63 Another mutation in the seed region of miR-96 (+14 C > A) was found in another Spanish family with autosomal dominant, progressive, high-frequency hearing loss. The fact that in both families the hearing loss was postlingual suggests that miR-96 may have a regulatory role in maintaining gene expression required for normal function, rather than inner ear development. Notably, this is the first study showing a nucleotide substitution in the seed region of a miRNA that is responsible for a human Mendelian disease. 63 Diminuendo (Dmdo) is an ENU-induced mouse model, with an A > T substitution in the miR-96 seed 64 ( Fig. 5) . These mice show progressive hearing impairment in heterozygotes and profound deafness in homozygotes, associated with hair cell defects. In homozygotes, most of the hair cells are degenerated by 4 weeks of age. Luciferase assays in transfected non-inner ear cells demonstrated that five mRNAs, Aqp5, Celsr2, Myrip, Odf2, and Ryk, are regulated by miR-96. 63, 64 These targets are suggested to be overexpressed in the inner ears of humans or mice with mutations in the miR-96 seed. However, while the level of Aqp5 and Celsr2 mRNAs was notably upregulated in the cochlear organ of Corti of the mutant Dmdo mice compared to wildtype, the differences in protein expression levels were small. 64 MiR-96 may function to fine-tune the expression level of these putative targets. It is also possible that other post translational regulation might play a role in regulating AQP5 and CELSR2 protein expression levels. These changes may indirectly affect the expression of many other genes, which are not direct targets of mir-96. A genome-wide approach revealed nearly 100 affected transcripts that were either down-or upregulated in the organ of Corti of mutant mice compared to wild-type mice. In particular, five genes that are well known in the inner ear were downregulated (prestin, oncomodulin, Pitpnm1, Gfi1, and Ptprq), although none of them has the seed region for mir-96. This suggested a downstream effect of epigenetic down-regulation caused by the miRNA that may help explain the mechanism behind the hearing impairment of these mice.
Conclusion
The advancements in the field of hereditary hearing loss have been dramatic since the mapping of the first chromosomal loci for X-linked deafness in 1988, SHL in 1990, and NSHL in 1992. Since then the discovery of a new gene or allele for hearing loss has occurred frequently, seemingly a new discovery every month. Along with the fact that connexin 26 accounts for a majority of congenital NSHL, these advances have provided new opportunities for diagnostics. Early identification of specific mutations using molecular diagnostics alleviates the need for other clinical tests. 66 It also facilitates predictions regarding the potential progressivity of the hearing loss (if not early onset profound) and other abnormalities, in the case of SHL. For example, children born with the PCDH15 R245X mutation are profoundly deaf, but the RP does not arise until about the age of 10. 67 Early diagnosis allows the family and physicians to be aware of impending blindness, which may dictate future treatment, for example, cochlear implantation.
Efforts are currently underway worldwide to develop therapeutics based on gene therapy, stem cells, and/or regenerative medicine. Caution must be taken, however, in raising immediate hopes in these areas for patients, since while there has been progress in basic research toward inner ear therapeutics, 68, 69 major technological and other hurdles remain. 70 Most important, there are many single-gene defects for inherited hearing loss yet to be discovered. While over 50 genes have been found for NSHL since the discovery of connexin 26, most mutations are rare and occur in one or a few families, making diagnostics today limited to only a handful of genes. Massively parallel sequencing (or deep sequencing) has been applied in a few cases toward gene discovery for hearing loss. 71, 72 As targeted genome capture, whole exome sequencing, and deep sequencing of entire genomes become more affordable, these techniques will be applied more to hereditary hearing loss as well, enabling further gene and mutation discovery. Most compelling, the complex genetic and protein interactions of the auditory system will be elucidated through studies of classical Mendelian phenotypes.
